ClinicalTrials.gov
ClinicalTrials.gov Menu

Efficacy Study of Sequential Therapy of Peginterferon Alfa-2a Following Entecavir in Patient With Chronic Hepatitis B. (POTENT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01220596
Recruitment Status : Unknown
Verified June 2011 by Hanyang University.
Recruitment status was:  Recruiting
First Posted : October 14, 2010
Last Update Posted : July 4, 2011
Sponsor:
Collaborator:
Roche Pharma AG
Information provided by:
Hanyang University

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Unknown
  Estimated Primary Completion Date : June 2013
  Estimated Study Completion Date : June 2013